New Rapid and Cost-Effective Tool for Monitoring DOACs

Thromb Haemost 2021; 121(01): 007
DOI: 10.1055/s-0040-1721485

T&H Insights

Helen Philippou

¹Division of Cardiovascular and Diabetes Research, The LIGHT Labs Clarendon Way, University of Leeds, Leeds, West Yorkshire, United Kingdom

References
1 Bavalia R, Middeldorp S, Weisser G, Espinola-Klein C. Treatment of venous thromboembolism in special populations with direct oral anticoagulants. Thromb Haemost 2020; 120 (06) 899-911
2 Giustozzi M, Agnelli G, Del Toro-Cervera J. et al. Direct oral anticoagulants for the treatment of acute venous thromboembolism associated with cancer: a systematic review and meta-analysis. Thromb Haemost 2020; 120 (07) 1128-1136
3 Maji D, Opneja A, Suster MA. et al. Monitoring DOACs with a novel dielectric microsensor: a clinical study. Thromb Haemost 2021; 121 (01) 58-69